Susceptibilities of ESBL-Producing Enterobacteriaceae to Ertapenem, Meropenem and Piperacillin-Tazobactam with and without Clavulanic Acid

Publisher： Karger

E-ISSN： 1421-9794|53|3|185-189

ISSN： 0009-3157

Source： Chemotherapy, Vol.53, Iss.3, 2007-03, pp. : 185-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Activity of Piperacillin/Tazobactam against Clinical Isolates of Extended- Spectrum β-Lactamase-Producing Enterobacteriaceae

By  

Chemotherapy, Vol. 44, Iss. 6, 1998-10 ,pp. : 377-384

Karger

Access to resources Recommend Favorite

In vitro Activity of Combination Therapy with Cefepime, Piperacillin-Tazobactam, or Meropenem with Ciprofloxacin against Multidrug-Resistant Pseudomonas aeruginosa Strains

By  

Chemotherapy, Vol. 49, Iss. 6, 2003-12 ,pp. : 294-297

Karger

Access to resources Recommend Favorite

Piperacillin with and without Tazobactam against Extended-Spectrum Beta-Lactamase-Producing Pseudomonas aeruginosa in a Rat Thigh Abscess Model

By  

Chemotherapy, Vol. 47, Iss. 4, 2001-05 ,pp. : 292-296

Karger

Access to resources Recommend Favorite

Serum Bactericidal Activity of Piperacillin/Tazobactam against Staphylococcus aureus, Piperacillin-Susceptible and Piperacillin-Resistant Escherichia coli and Pseudomonas aeruginosa

By  

Chemotherapy, Vol. 50, Iss. 1, 2004-04 ,pp. : 27-30

Karger

Access to resources Recommend Favorite

In vitro Activity of Piperacillin/Tazobactam against 615 Pseudomonas aeruginosa Strains Isolated in Intensive Care Units

By  

Chemotherapy, Vol. 44, Iss. 5, 1998-08 ,pp. : 305-312

Karger

Access to resources Recommend Favorite